Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomised rats

European Journal of Neuroscience

Volumn 39, Issue 2, 2014, Pages 266-274

  Pudell, Claudia ^a   Vicente, Bianca A ^a   Delattre, Ana M ^a   Carabelli, Bruno ^a   Mori, Marco A ^a   Suchecki, Deborah ^b   Machado, Ricardo B ^b   Zanata, Sílvio M ^a   Visentainer, Jesuí V ^c   de Oliveira Santos, Oscar ^c   Lima, Marcelo M S ^a   Ferraz, Anete C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

3 polyunsaturated fatty acids; BDNF; Depression; Memory; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; NEUROTROPHIC FACTOR; NEUROTROPHIN; OLEIC ACID; PALMITIC ACID; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN DEVELOPMENT; BRAIN LEVEL; CELL SURVIVAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; FEMALE; FORCED SWIM TEST; IMMUNOASSAY; LIPID ANALYSIS; MALE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD TEST; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONIN METABOLISM;

BDNF; DEPRESSION; MEMORY; SEROTONIN; Ω-3 POLYUNSATURATED FATTY ACIDS;

ANIMALS; ANXIETY DISORDERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; FISH OILS; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; NEUROPSYCHOLOGICAL TESTS; OLFACTORY BULB; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; SEROTONIN;

EID: 84892672355     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12406     Document Type: Article

References (53)

1. Asl, N.A., Sheikhzade, F., Torchi, M., Roshangar, L. & Khamnei, S. (2008) Long-term regular exercise promotes memory and learning in young but not in older rats. Pathophysiology, 15, 9-12.
2. Bligh, E.G. & Dyer, W.J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys., 37, 911-917.
3. Borre, Y., Bosman, E., Lemstra, S., Westphal, K.G., Olivier, B. & Oosting, R.S. (2012) Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration. Neuropharmacology, 62, 2010-2017.
4. Borsonelo, E.C. & Galduroz, J.C. (2008) The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions. Prostag. Leukotr. Ess., 78, 237-245.
5. Breuer, M.E., Groenink, L., Oosting, R.S., Westenberg, H.G. & Olivier, B. (2007) Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biol. Psychiat., 61, 990-995.
6. Broadhurst, P.L. (1960) The place of animal psychology in the development of psychosomatic research. Fortschr. Psychosom. Med., 1, 63-69.
7. Cairncross, K.D., Cox, B., Forster, C. & Wren, A.F. (1978) A new model for the detection of antidepressant drugs: olfactory bulbectomy in the rat compared with existing models. J. Pharmacol. Method., 1, 131-143.
8. Calon, F. & Cole, G. (2007) Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostag. Leukotr. Ess., 77, 287-293.
9. Canbeyli, R. (2010) Sensorimotor modulation of mood and depression: an integrative review. Behav. Brain Res., 207, 249-264.
10. Colangelo, L.A., He, K., Whooley, M.A., Daviglus, M.L. & Liu, K. (2009) Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition, 25, 1011-1019.
11. Cryan, J.F., Markou, A. & Lucki, I. (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci., 23, 238-245.
12. Deussing, J.M. (2006) Animal models of depression. Drug Discov. Today, 3, 375-383.
13. Duman, R.S., Heninger, G.R. & Nestler, E.J. (1997) A molecular and cellular theory of depression. Arch. Gen. Psychiat., 54, 597-606.
14. Elfving, B., Plougmann, P.H. & Wegener, G. (2010) Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. J. Neurosci. Meth., 187, 73-77.
15. Ennaceur, A., Michalikova, S., Bradford, A. & Ahmed, S. (2005) Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav. Brain Res., 159, 247-266.
16. Ferraz, A.C., Kiss, A., Araujo, R.L., Salles, H.M., Naliwaiko, K., Pamplona, J. & Matheussi, F. (2008) The antidepressant role of dietary long-chain polyunsaturated n-3 fatty acids in two phases in the developing brain. Prostag. Leukotr. Ess., 78, 183-188.
17. Ferraz, A.C., Delattre, A.M., Almendra, R.G., Sonagli, M., Borges, C., Araujo, P., Andersen, M.L., Tufik, S. & Lima, M.M. (2011) Chronic omega-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol. Behav. Brain Res., 219, 116-122.
18. Galter, D. & Unsicker, K. (2000) Sequential activation of the 5-HT1A serotonin receptor and TrkB induces the serotonergic neuronal phenotype. Mol. Cell. Neurosci., 15, 446-455.
19. Gomez-Pinilla, F. (2008) Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci., 9, 568-578.
20. Harkin, A.K., Kelly, J.P. & Leonard, B.E. (2003) A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clin. Neurosci. Res., 3, 253-264.
21. Hellweg, R., Zueger, M., Fink, K., Hortnagl, H. & Gass, P. (2007) Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol. Dis., 25, 1-7.
22. Hendriksen, H., Meulendijks, D., Douma, T.N., Bink, D.I., Breuer, M.E., Westphal, K.G., Olivier, B. & Oosting, R.S. (2012) Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats. Neuropharmacology, 62, 270-277.
23. Hozumi, S., Nakagawasai, O., Tan-No, K., Niijima, F., Yamadera, F., Murata, A., Arai, Y., Yasuhara, H. & Tadano, T. (2003) Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav. Brain Res., 138, 9-15.
24. Jancsar, S.M. & Leonard, B. (1984) Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry, 8, 263-269.
25. Joseph, J.D. & Ackman, R.G. (1992) Capillary column gas-chromatographic method for analysis of encapsulated fish oils and fish oil ethyl-esters - collaborative study. J. AOAC Int., 75, 488-506.
26. Karege, F., Bondolfi, G., Gervasoni, N., Schwald, M., Aubry, J.M. & Bertschy, G. (2005a) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiat., 57, 1068-1072.
27. Karege, F., Vaudan, G., Schwald, M., Perroud, N. & La Harpe, R. (2005b) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res., 136, 29-37.
28. Kelly, J.P., Wrynn, A.S. & Leonard, B. (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Therapeut., 74, 299-316.
29. Kurita, M., Nishino, S., Kato, M., Numata, Y. & Sato, T. (2012) Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study. PLoS One, 7, e39212.
30. López-Muñoz, F. & Alamo, C. (2009) Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr. Pharm. Design, 15, 1563-1586.
31. Machado, R.B., Tufik, S. & Suchecki, D. (2008) Chronic stress during paradoxical sleep deprivation increases paradoxical sleep rebound: association with prolactin plasma levels and brain serotonin content. Psychoneuroendocrino., 33, 1211-1224.
32. Martinowich, K. & Lu, B. (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacol., 33, 73-83.
33. McNamara, R.K. & Carlson, S.E. (2006) Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostag. Leukotr. Ess., 75, 329-349.
34. McNamara, R.K., Able, J., Liu, Y., Jandacek, R., Rider, T., Tso, P. & Lipton, J.W. (2009) Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. J. Psychiatr. Res., 43, 656-663.
35. Moriguchi, S., Han, F., Nakagawasai, O., Tadano, T. & Fukunaga, K. (2006) Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice. J. Neurochem., 97, 22-29.
36. Mucignat-Caretta, C., Bondi, M. & Caretta, A. (2006) Time course of alterations after olfactory bulbectomy in mice. Physiol. Behav., 89, 637-643.
37. Naliwaiko, K., Araujo, R.L., Da Fonseca, R.V., Castilho, J.C., Andreatini, R., Bellissimo, M.I., Oliveira, B.H., Martins, E.F., Curi, R., Fernandes, L.C. & Ferraz, A.C. (2004) Effects of fish oil on the central nervous system: a new potential antidepressant? Nutr. Neurosci., 7, 91-99.
38. Oral, E., Canpolat, S., Yildirim, S., Gulec, M., Aliyev, E. & Aydin, N. (2012) Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res. Bull., 88, 454-459.
39. Ostrovskaya, R.U., Gruden, M.A., Bobkova, N.A., Sewell, R.D.E., Gudasheva, T.A., Samokhin, A.N., Seredinin, S.B., Noppe, W., Sherstnev, V.V. & Morozova-Roche, L.A. (2007) The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. J. Psychopharmacol., 21, 611-619.
40. Piccinni, A., Marazziti, D., Catena, M., Domenici, L., Del Debbio, A., Bianchi, C., Mannari, C., Martini, C., Da Pozzo, E., Schiavi, E., Mariotti, A., Roncaglia, I., Palla, A., Consoli, G., Giovannini, L., Massimetti, G. & Dell'Osso, L. (2008) Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disorders, 105, 279-283.
41. Sato, A., Nakagawasai, O., Tan-No, K., Onogi, H., Niijima, F. & Tadano, T. (2010) Influence of olfactory bulbectomy on maternal behavior and dopaminergic function in nucleus accumbens in mice. Behav. Brain Res., 215, 141-145.
42. Song, C. & Leonard, B.E. (2005) The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. R., 29, 627-647.
43. Song, C. & Wang, H. (2010) Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 760-768.
44. Song, C., Zhang, X.Y. & Manku, M. (2009) Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effect of chronic ethyl-eicosapentaenoate treatment. Neurobiol. Dis., 7, 14-22.
45. Su, H.-M. (2010) Mechanisms of n-3 fatty acids-mediated development and maintenance of learning memory performance. J. Nutr. Biochem., 21, 364-373.
46. Venna, V.R., Deplanque, D., Allet, C., Belarbi, K., Hamdane, M. & Bordet, R. (2009) PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrino., 34, 199-211.
47. Vines, A., Delattre, A.M., Lima, M.M., Rodrigues, L.S., Suchecki, D., Machado, R.B., Tufik, S., Pereira, S.I., Zanata, S.M. & Ferraz, A.C. (2012) The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology, 62, 184-191.
48. Wang, D., Noda, Y., Tsunekawa, H., Zhou, Y., Miyazaki, M., Senzaki, K. & Nabeshima, T. (2007) Behavioral and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav. Brain Res., 178, 262-273.
49. Wang, J.W., Dranovsky, A. & Hen, R. (2008) The when and where of BDNF and the antidepressant response. Biol. Psychiat., 63, 640-641.
50. Wieronska, J.M. & Papp, P.A. (2001) Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats. Pol. J. Pharmacol., 53, 517-525.
51. Wu, A., Yinga, Z. & Gomez-Pinilla, F. (2008) Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience, 155, 751-759.
52. Yu, H. & Chen, Z. (2011) The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol. Sin., 32, 3-11.
53. Zueger, M., Urani, A., Chourbaji, S., Zacher, C., Roche, M., Harkin, A. & Gass, P. (2005) Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci. Lett., 374, 142-146.